|
|
 |
Trial Information
Summary: Ariad Pharmaceuticals, Inc. is currently recruiting subjects to participate in an experimental study for female patients with Recurrent or Persistent Endometrial Cancer.
Study drug and procedures will be made available to you at no
cost.
To qualify, you must:
- Be 18 years of age or older
- Have progression of your endometrial cancer (cancer of the
lining of the uterus) within the last 3 months
- Have presence of at least one measurable lesion
- Have adequate bone marrow, liver and kidney function
You will not qualify if:
- You are pregnant or lactating
- Have had more than 2 treatments of chemotherapy
- Have had any other primary malignancy in the past three
years
- Have HIV infection
- Have an uncontrolled Cardiovascular disease
- Have any other life threatening illness or organ system
dysfunction
For more information,
|
Contact:
Margaret Sheehan
Biomedical Research Alliance of New York
Schwartz Gynecologic Oncology, PLLC
500 West Main Street, Suite 209
Babylon, NY 11702
Telephone: 631-224-9521 x 104
|
|

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:45:59 AM
|
 |
|